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Abstract
Introduction: We aimed to explore the involvement of a multiallelic functional polymorphism in knee
osteoarthritis (OA) susceptibility as a prototype of possible genetic factors escaping GWAS detection.
Methods: OA patients and controls from three European populations (Greece, Spain and the UK) adding up to
1003 patients (716 women, 287 men) that had undergone total knee joint replacement (TKR) due to severe
primary OA and 1543 controls (758 women, 785 men) lacking clinical signs or symptoms of OA were genotyped
for the D6S1276 microsatellite in intron 1 of BMP5. Genotype and mutiallelic trend tests were used to compare
cases and controls.
Results: Significant association was found between the microsatellite and knee OA in women (P from 3.1 x10-4 to
4.1 x10-4 depending on the test), but not in men. Three of the alleles showed significant differences between
patients and controls, one of them of increased risk and two of protection. The gender association and the allele
direction of change were very concordant with those previously reported for hip OA.
Conclusions: We have found association of knee OA in women with the D6S1276 functional microsatellite that
modifies in cis the expression of BMP5 making this a sounder OA genetic factor and extending its involvement to
other joints. This result also shows the interest of analysing other multiallelic polymorphisms.
Introduction
Investigation of the genetic component of osteoarthritis
(OA) susceptibility has yielded the identification of sev-
eral loci achieving genome-wide significance or consis-
tent replication [1-3]. These loci are insufficient to
account for the heritability of OA, which has been esti-
mated as 49 to 78% for knee OA in twin and family stu-
dies [4-6]. Multiple possible causes of this discrepancy,
which has become known as the missing heritability pro-
blem of complex diseases, have been discussed [7]. Some
have a particular importance in OA, like the difficulties
in discriminating between cases and controls, the varia-
bility in phenotype definitions and the relatively small
size of genome wide association studies (GWAS) in
which OA has been studied in comparison with other
diseases [3,8]. Other causes are shared by most complex
diseases. They include genetic variants that are not well
ascertained with the current GWAS and interactions
between genetic variants, and between genetic and envir-
onmental factors that are beyond the analysis and design
of current studies. Among the variants escaping GWAS
detection are rare-frequency variants, even if they have a
large effect, and variants with multiple alleles. The latter
group is made of large structural variants and small repe-
titive sequences. They could escape GWAS detection
because their multiple alleles cannot have sufficient link-
age disequilibrium (LD) with bi-allelic markers as the sin-
gle nucleotide polymorphisms (SNPs) analyzed in
GWAS. One of these multi-allelic polymorphisms, a vari-
able number tandem repeat (VNTR) polymorphism in
the gene for asporin, has shown consistent association
with OA in Asians and less so in Europeans [9,10]. Other
multi-allelic polymorphisms have also been found asso-
ciated with OA, but none of these studies has been fol-
lowed by an attempt of replication [11-14].
One of the OA-associated multi-allelic polymorphisms is
an intronic microsatellite in BMP5 (bone morphogenetic
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protein 5). It has been associated with hip OA in UK
women and its allelic variants showed a regulatory effect
on the BMP5 promoter in vitro [11]. BMP5 is a good can-
didate gene for OA because BMPs are members of the
transforming growth factor (TGF)-beta superfamily that
were identified by their involvement in cartilage and bone
development. Now, they are known to give morphogenetic
signals directing tissue organization throughout the body.
In particular, BMP5 is implicated in bone morphogenesis
and in the formation of the skeletal pattern, in addition to
having roles in other organs [15]. It is expressed in prolif-
erating zone chondrocytes of the growth plate and is very
markedly increased by hypertrophic differentiation. This is
in contrast with other BMPs [16]. In chondrocytes, upon
binding to the BMP membrane receptors, BMP5 leads to
phosphorylation of p38 MAP kinase, ERK and SMAD-1,-5,
and -8. Nuclear accumulation of phosphor-SMADs leads
to over-expression of genes involved in cartilage homeos-
tasis as proteoglycan and of markers of hypertrophic differ-
entiation [17]. At a cellular level, this translates into an
increase of chondrocyte proliferation and in the synthesis
of cartilage matrix [16]. In addition, BMP5 expression is
decreased in OA synovia [18] and bone [19]. These
changes in expression together with the BMP5 chondro-
genic role and involvement in chondrocyte hypertrophy
indicate BMP5 relevance for OA pathogenesis.
We have genotyped the D6S1276 BMP5 microsatellite
in a large set of knee OA cases and disease-free controls
and found an association with knee OA in women. The
associated alleles and the gender specificity are similar to
those previously found in UK women with hip OA. This
finding reinforces the need to explore the involvement of
BMP5 genetic variation in OA and extends it to OA in
other joints. It also shows that other multi-allelic variants
are worthy of examination for their possible involvement
in OA.
Materials and methods
Patients and controls
OA patients and controls were recruited at Thessaly in
Greece, Santiago de Compostela in Spain and Oxford in
the UK. All were European Caucasians. There were 1,003
patients (716 women, 287 men) who had undergone total
knee joint replacement (TKR) due to severe primary OA.
The 1,543 controls (758 women, 785 men) lacked clinical
signs of OA. Full details about the patients and the controls
have been reported [20]. In the Greek collection, there
were 369 TKR patients (298 women and 71 men) and 383
controls (241 women and 142 men). TKR patients had a
Kellgren-Lawrence (K/L) grade > 2 prior to surgery and an
age range of 40 to 90 years. Rheumatoid arthritis, other
autoimmune diseases, chondrodysplasias, infection-induced
OA, and post-traumatic OA were excluded. The controls
had a K/L grade of 0 and had undergone treatment for
injuries and fractures. They were from 46 to 88 years old.
In the Spanish collection, there were 274 TKR patients
(222 women and 52 men) and 462 controls (161 women
and 301 men). Patients were selected as consecutive
patients, of 55-80 years of age at the time of surgery, and
undergoing TKR if a rheumatologist considered them to
suffer from primary OA. Exclusion criteria were inflamma-
tory, infectious, or traumatic joint pathology and lesions
due to crystal deposition or osteonecrosis. Controls were
older than 55 years of age and were selected during preo-
perative work-up for elective surgery other than joint sur-
gery and without symptoms or signs of OA. The UK
collection included 360 TKR patients (196 women and 164
men) of 56 to 85 years of age and 698 controls (356
women and 342 men) of 55 to 89 years of age. Patients
showed symptoms and signs of OA of sufficient severity to
require surgery, including a K/L grade ≥ 2 (> 90% of them
had grade 3 or 4). Inflammatory arthritis (rheumatoid,
polyarthritic or autoimmune disease) was excluded, as was
post-traumatic or post-septic arthritis. Controls had no
signs or symptoms of arthritis or joint disease (pain, swel-
ling, tenderness or restriction of movement). All patients
and controls gave their written informed consent and the
use of their DNA for OA genetic studies was approved by
the respective ethics committees.
Genotyping
The BMP5 microsatellite D6S1276 was genotyped by
length analysis of the PCR products obtained with primers
5’-FAM-atgcctggcaaatgtcaagt-3’ and 5’-gcccagcatccctgat-
taag-3’. Size of the fluorescence-labeled products was
determined by capillary electrophoresis on an ABI 3130xl
Avant Genetic Analyzer (Applied Biosystems, Foster City,
CA, USA) and the corresponding microsatellite genotypes
were determined using GeneMapper 3.5 software (Applied
Biosystems). Several samples with different genotypes
were sequenced to assess the accuracy of results with the
Big Dye v3.1 Ready Reaction Kit (Applied Biosystems).
Statistical analysis
Analyses were based on Power Marker software [21] and
on the R software implementation of the Cochran-Mantel-
Haenszel stratified test [22]. Exact tests for Hardy Wein-
berg equilibrium (HWE) were run with the Markov Chain
Monte Carlo method. Deviation from HWE motivated
analyses based in genotype 2 × n contingency tables and
the multi-allelic trend test. These two tests are totally
insensitive to HWE deviations [23]. Significance of the
genotype test was obtained with the Markov Chain Monte
Carlo method to avoid the limitations that sparse contin-
gency tables pose to the asymptotic chi squared distribu-
tion method. Rare genotypes, with frequency below 1.0%
were excluded from analysis. In this way, the degrees of
freedom were reduced and the tests became more robust.
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These analyses were conducted collection by collection
and with the three collections together. Heterogeneity
between collections was assessed with the population dif-
ferentiation test applied to the controls and with the
inconsistency (I2) statistic [24] applied to the Cramer’s V
effect size, which is the effect size most commonly used
for 2 × n contingency tables. Combined analysis was done
considering all data together and stratified by sample
collection with the Cochran-Mantel-Haenszel method for
2 × n tables.
Results
D6S1276 genotypes
A total of 2,545 DNA samples were available for study.
Valid genotypes for the D6S1276 microsatellite were
obtained from 93.32% of them with a similar distribution
of the genotype call rate between the three sample collec-
tions and between cases and controls. A total of ten dif-
ferent alleles were observed, ranging from five to
fourteen tetranucleotide repeats (Table 1). The most
common was the ten-repeats allele (41.2%), followed by
the eight-, nine- and eleven-repeats alleles (20.1, 20.2%
and 13.4%, respectively). All the remaining alleles showed
a frequency below 1.0%. These 10 alleles appeared in 28
different genotypes (not shown). The most frequent was
the 10/10 genotype (17.7%) followed by the 10/9 and 10/
8 genotypes (16.8 and 15.9%, respectively). Up to 14 gen-
otypes showed a frequency below 1.0% and they were
excluded from further study (for remaining genotype fre-
quencies, see Tables S1- S3 in Additional file 1). In this
way, 62 samples (or 2.4% of all the genotyped samples)
were left out, with 2,313 remaining in subsequent ana-
lyses. They showed 14 different genotypes made of five
alleles (from seven to eleven tetranucletotide repeats).
There was a significant deviation from HWE in the UK
(P = 0.008) controls, but not in the Spanish (P = 0.6) or
Greek controls (P = 0.3). The deviation motivated a careful
revision of the genotypes, and their confirmation by
sequencing. Also we compared the reported BMP5 allele
frequency distribution [11] with the one obtained by us in
UK women and no difference was found (P = 0.7). In addi-
tion, no difference was detected between the three collec-
tions in our study (P = 0.9). These results showed the
accuracy of the genotypes. However, we used tests insensi-
tive to deviations from HWE as more appropriate for our
data: genotype test and the multi-allelic trend tests [23].
Association analyses by sample collection
Previously reported association of BMP5 with hip OA
was only observed in women [11], therefore a gender-
stratified analysis was done (Tables 2 and 3). Significant
differences between knee OA patients and controls were
only observed in women from the UK and from Greece
(Table 4). In the Greek women, the multi-allelic trend
test and the genotype test provided very similar results,
with a significant difference between knee OA patients
and controls in both of them (P = 0.021 and P = 0.032).
In the UK women the two tests were discordant. The
multi-allelic trend test showed a significant difference
(P = 0.028), whereas the genotype test was not significant
(P = 0.3). This discordance could be partly related to the
greater power of the first test that has four degrees of
freedom, in contrast with the thirteen corresponding to
the genotype test. On comparison, no significant differ-
ences were observed in the Spanish women or in any of
the men (Table 4).
Combined association across sample collections
In a first analysis, we simply combined all samples
together without considering their origin (Table 5). This
approach was justified in the lack of heterogeneity
of D6S1276 effects between the three sample collections
Table 1 Allele counts and frequency of the D6S1276 BMP5 microsatellite in patients with knee osteoarthritis (OA) and
in controls from the three sample collections
Controls Patients with knee OA
Allele Spain Greece UK Total Spain Greece UK Total
Count % Count % Count % Count % Count % Count % Count % Count %
5 1 0.1 1 0.0 3 0.4 3 0.2
6 1 0.1 2 0.3 2 0.2 5 0.2 1 0.2 4 0.6 5 0.3
7 39 4.4 23 3.4 58 4.4 120 4.2 18 3.6 12 1.7 35 4.9 65 3.4
8 160 18.2 126 18.9 256 19.6 542 19.0 116 23.2 139 20.1 158 22.3 413 21.7
9 188 21.4 147 22.0 282 21.6 617 21.6 97 19.4 139 20.1 104 14.7 340 17.9
10 362 41.2 264 39.5 525 40.3 1151 40.4 210 42.0 292 42.2 303 42.8 805 42.4
11 115 13.1 98 14.7 168 12.9 381 13.4 53 10.6 102 14.7 101 14.3 256 13.5
12 11 1.3 6 0.9 12 0.9 29 1.0 5 1.0 4 0.6 4 0.6 13 0.7
13 2 0.3 1 0.1 3 0.1
14 1 0.1 1 0.0
Total 878 668 1,304 2,850 500 692 708 1,900
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(I2 = 0.0%) and lack of differences in the microsatellite
genotypes between the three populations (above). Both the
multi-allelic trend test and the genotype test were clearly
significant in women (P = 3.3 × 10-4, and P = 4.1 × 10-4,
respectively). We also performed a combined analysis
accounting for origin of the samples with the Cochran-
Mantel-Haenszel test applied to the 2 × 14 × 3 genotype
contingency table (Table 5). The result was very similar to
the simple pooling showing association in the female
patients (P = 3.8 × 10-4). No association was observed in
men (Table 3).
Inspection of the genotypes showed that the difference
between female patients with knee OA and female con-
trols was not due to a single genotype but to several
(Figure 1), including an increase in patients of the 10/8
genotype (20.4% vs. 12.6%, odds ratio (OR) 1.77, 95% CI
1.32-2.39, P = 0.0002) and a decrease of the 10/9 genotype
(14.4% vs. 21.0%, OR 0.63, 95% CI 0.47-0.84, P = 0.002).
No differences were detected when the same comparisons
were made in men although variation was in the same
direction
Discussion
Our study has identified the D6S1276 microsatellite in
BMP5 as a new genetic factor for knee OA in women. The
D6S1276 microsatellite has previously been associated
with hip OA [11]. Concordance with this study extends
beyond the association because the two studies found
association in women and with a similar pattern of alleles.
The concordance of our findings was very clear with the
first set of samples in the hip OA study, where the risk
allele was also the eight-repeats allele (P = 0.006) and pro-
tection was mediated by the seven-repeats allele (P = 0.03),
and other alleles showed changes in the same direction
[11]. The second set of samples was not associated with
D6S1276 in Wilkins et al., but in the combined analysis of
the two sets the association remained as well as the protec-
tive effect of the seven-repeats allele (P = 0.03) and the
Table 2 Allele counts and frequency of the D6S1276 BMP5 microsatellite in women with knee osteoarthritis (OA) and
control women from the three sample collections
Controls Patients with knee OA
Spain Greece UK Total Spain Greece UK Total
Alleles Count % Count % Count % Count % Count % Count % Count % Count %
5 1 0.3 1 0.1
6 1 0.2 1 0.1 1 0.2 4 0.7 5 0.4
7 16 5.2 20 4.8 28 4.4 64 4.7 16 3.9 11 2 17 4.4 44 3.2
8 52 17 70 16.8 117 18.2 239 17.5 91 22.2 114 20.2 95 24.6 300 22.1
9 66 21.6 99 23.8 137 21.3 302 22.1 82 20 113 20 56 14.5 251 18.5
10 126 41.2 159 38.2 263 41 548 40.2 174 42.4 240 42.6 164 42.5 578 42.5
11 42 13.7 65 15.6 87 13.6 194 14.2 43 10.5 79 14 50 13 172 12.6
12 4 1.3 3 0.7 9 1.4 16 1.2 3 0.7 3 0.5 3 0.8 9 0.7
Total 306 416 642 1,364 410 564 386 1,360
Table 3 Allele counts and frequency of the D6S1276 BMP5 microsatellite in men with knee osteoarthritis (OA) and in
control men from the three sample collections
Controls Knee OA
Spain Greece UK Total Spain Greece UK Total
Alleles Count % Count % Count % Count % Count % Count % Count % Count %
5 1 0.2 1 0.1 2 0.6 2 0.4
6 1 0.2 2 0.8 1 0.2 4 0.3
7 23 4 3 1.2 30 4.5 56 3.8 2 2.2 1 0.8 18 5.6 21 3.9
8 108 18.9 56 22.2 139 21 303 20.4 25 27.8 25 19.5 63 19.5 113 20.9
9 122 21.3 48 19 145 21.9 315 21.2 15 16.7 26 20.3 48 14.9 89 16.5
10 236 41.3 105 41.7 262 39.6 603 40.6 36 40 52 40.6 139 43.2 227 42.0
11 73 12.8 33 13.1 81 12.2 187 12.6 10 11.1 23 18 51 15.8 84 15.6
12 7 1.2 3 1.2 3 0.5 13 0.9 2 2.2 1 0.8 1 0.3 4 0.7
13 2 0.8 1 0.2 3 0.2
14 1 0.2 1 0.1
Total 572 252 662 1,486 90 128 322 540
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direction of change of the eight-repeats allele. Therefore,
our study does not amount to a formal replication because
of the difference in the involved joint, but strongly rein-
forces the evidence in support of the implication of this
BMP5 polymorphism in OA susceptibility. In addition, our
finding indicates that this microsatellite could be asso-
ciated with independence of the joint.
It is very unlikely that the association of D6S1276 with
knee OA could be due to confounding by population
stratification. The association was found in two indepen-
dent sample collections with origin in Greece and the
UK, and reinforced in the analyses with samples from
Spain without any detectable heterogeneity as shown by
the lack of inconsistency (I2 = 0%) and by the very simi-
lar results obtained pooling data from the three collec-
tions or using the Cochran-Mantel-Haenszel approach.
Lack of differences in D6S1276 between collections was
also shown by the absence of population differentiation
between the controls (P = 0.91), and by lack of signifi-
cant differences in any of the pairwise comparisons
between controls, and differences only in patients from
Greece (Table S2 in Additional file 1). In addition, there
are arguments to exclude significant population stratifi-
cation in each of the three sample collections taken
individually. The UK samples were genotyped in the
recently reported arcOGEN GWAS [1]. In this study no
significant population stratification was detected (geno-
mic control inflation factor l1000 = 1.009). The Spanish
samples are from subjects reporting a Spanish origin
extending for two or more generations. In fact, 94.7% of
the patients and 95.4% of the controls are of an even
more homogeneous ancestry, as all their known ances-
tors were from Galicia, a region in the North-West of
Spain. Excluding subjects of a wider Spanish ancestry
did not alter the results (not shown). Finally, the Greek
collection was made of individuals of Greek descent
who were inhabitants of Central Greece and ethnic or
racial differences between patients and controls were
not detected in multiple previous studies [13,14,20,25].
The identification of the D6S1276 microsatellite as an
important polymorphism in hip OA has been the fruit of
successive studies by the group of John Loughlin
[11,26-29]. Initially, linkage with hip OA was detected in
chromosome 6 after stratification by affected joint of a
genome-wide linkage study performed in sibling-pairs
who had undergone total hip replacement (THR) for pri-
mary OA [26]. The linked region was very broad (> 50
cM). Fine mapping with additional microsatellites and
THR families reduce the locus to 11.4 cM at 6p12.3-q13
and showed that it was specific to women [27]. This
study also increased the statistical evidence for linkage.
Two candidate genes in the interval were excluded by
association analysis with SNPs mapping to their coding
sequence and promoter, COL9A1 [27] and BMP5 [28].
However, a subsequent study including additional micro-
satellites confirmed the same peak of linkage and found
association in intron 1 (D6S1276) and 3’ to BMP5, bring-
ing forward the possibility that the causal polymorphism
could be in cis-regulatory sequences of this gene [29].
This hypothesis was tested in the last study to date,
where more samples and polymorphisms within intron 1
were analyzed [11]. Here, association was confirmed with
D6S1276 and found only with one of the new poly-
morphisms. Subsequent functional analysis with reporter
gene assays showed that only D6S1276 was able to mod-
ify the expression of the luciferase gene under the BMP5
promoter [11]. This analysis also demonstrated a signifi-
cant amount of variability of modifier effect depending
on the cell line where the study was done, the D6S1276
allele and the alleles at three nearby SNPs.
The variability of effects of D6S1276 is congruent with
what is known of the regulation of BMP5. In effect, regu-
lation of this gene is very modular, precise and complex
involving multiple cis-acting enhancers with tissue- and
location-specific effects [17,30,31]. This has been clearly
demonstrated in the mouse, where mutations in BMP-5
showed cartilage and bone defects affecting seemingly
unrelated skeletal elements in addition to several soft-tis-
sue organs [15]. This indicated a complex pattern of tran-
scription regulation that was confirmed with the
identification of multiple cis-regulatory modular enhan-
cers each of them acting in particular tissues or even in
Table 4 Association of the D6S1276 BMP5 microsatellite
with knee osteoarthritis (OA) by sample collection and
by gender
Number P-values
Collection Gender Controls Knee
OA
Multi-allelic
trend test
Genotype
test
Spain women 149 200 0.2 0.5
men 277 43 0.4 0.4
all 426 243 0.1 0.5
Greece women 205 275 0.021 0.032
men 120 63 0.8 0.6
all 325 338 0.2 0.09
UK women 312 187 0.028 0.2
men 325 157 0.09 0.3
all 637 344 0.0059 0.1
Table 5 Association of the D6S1276 BMP5 microsatellite
with knee osteoarthritis (OA0 across sample collections
Multi-allelic trend test Genotype test
Gender Simple pooling Simple pooling CMHa
Women 0.00033 0.00041 0.00038
Men 0.11 0.2 0.4
All 0.00073 0.0076 0.0092
aCMH, Cochran-Mantel-Haenszel stratified analysis
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different regions of the same organ [30,31]. Most of these
enhancers are 3’ to the coding sequence but also an
enhancer directing expression in different areas of the
mouse ribs has been identified in one of the Bmp5
introns [31]. A similar complex and precise regulation
seems to be present in humans because analysis of differ-
ential allelic expression showed extreme variability
between the joint tissues with differences even between
regions of the same cartilage surface in function of their
proximity to the OA lesion [32].
Association of D6S1276 is not contradicted by the lack
of replication in the Spanish collection because it was
most likely due to lack of power (below 0.46 for the most
significant differences found in the current study) and not
to significant differences between the Spanish and the
other two collections (Table S4 in Additional file 1). In
addition, the association we have found was not ques-
tioned by the lack of an association signal in the GWAS
because the multiplicity of the microsatellite-associated
alleles makes for very poor correlation with any bi-allelic
SNP. This has been already shown in the previous studies
of hip OA, where none of the BMP5 SNPs analyzed
accounted for the association of D6S1276 [11,28]. There-
fore, our initial hypothesis positing that some of the
unidentified genetic susceptibility to OA could be in
multi-allelic polymorphisms is supported by our results in
BMP5 and should motivate analysis of other similar loci.
In addition, the lack of linkage with knee OA in the origi-
nal genome-wide linkage study that brought attention to
the BMP5 locus is not against the association we have
found, because this study included fewer families with
knee OA (34 families, including affected women and men)
than with hip OA in women (85 families plus 44 families
with hip OA in men), and therefore was less sensitive
to detect any difference specific to the women of this
subgroup [26].
Conclusions
We have found association of knee OA in women with
the D6S1276 functional microsatellite that modifies in cis
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Figure 1 Comparison of the individual genotypes between women with knee osteoarthritis (OA) and controls. The odds ratio (OR) and
95% CI corresponding to the specified genotypes relative to the remaining are represented for frequencies in patients in relation to controls.
The order is from protective to risk genotype.
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the expression of BMP5. The results are very concordant
with those observed previously for hip OA, making this
association sounder, and extending its range of involve-
ment to other joints. These results also show the interest
of analyzing other multi-allelic polymorphisms for their
possible role in OA susceptibility.
Additional material
Additional file 1: Genotype frequencies and comparison across
populations. Genotype counts and frequencies in patients with knee OA
and in controls from the three sample collections are provided as total,
in women and in men. The genotype frequencies were also compared
pairwise between the sample collections.
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